AEON Biopharma (AEON) Other Non Operating Income (2021 - 2026)
AEON Biopharma (AEON) posted Other Non Operating Income of -$171000.0 for Q4 2025, down 351.47% sequentially from $68000.0 in Q3 2025, and down 17200.0% YoY from N/an in Q4 2024.
AEON Biopharma (AEON) Other Non Operating Income (2021 - 2026) Analysis & Trends
AEON Biopharma has reported Other Non Operating Income for 5 years, with the latest figure at -$171000.0 in Q4 2025.
- Quarterly Other Non Operating Income fell 17200.0% year-over-year to -$171000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $92000.0 (down 1.08% YoY) and the FY2025 annual result came in at $92000.0, down 3.16% from the prior year.
- Other Non Operating Income declined to -$171000.0 in Q4 2025 per AEON's latest filing, from $68000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $7.2 million in Q1 2021 and troughed at -$3.7 million in Q2 2021.
- A 5-year average of $878258.2 and a median of $92000.0 in 2025 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 257.89% in 2025, down 17200.0% in 2025.
- Over 5 years, Other Non Operating Income stood at $1.1 million in 2021, then tumbled by 86.79% to $147000.0 in 2022, then increased by 26.53% to $186000.0 in 2023, then slumped by 99.46% to $1000.0 in 2024, then sank by 17200.0% to -$171000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$171000.0, $68000.0, and $92000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AEON Biopharma | 9.71 Mn | 6.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 36,000.00 |
| Dec 31, 2025 | -171,000.00 |
| Sep 30, 2025 | 68,000.00 |
| Jun 30, 2025 | 92,000.00 |
| Mar 31, 2025 | 103,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 34,000.00 |
| Mar 31, 2024 | 39,000.00 |
| Sep 30, 2023 | 186,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 64,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Sep 30, 2022 | 141,000.00 |
| Jun 30, 2022 | 2.17 Mn |
| Mar 31, 2022 | 3.03 Mn |
| Dec 31, 2021 | 1.11 Mn |
| Sep 30, 2021 | 6.09 Mn |
| Jun 30, 2021 | -3.66 Mn |
| Mar 31, 2021 | 7.17 Mn |